£12 million funding awarded to advance innovative cancer projects across the UK. Twenty-three companies will benefit from a share of £12 million from the Innovate UK Cancer Therapeutics programme. The Cancer Therapeutics programme focuses on developing life-changing cancer treatments, including immunotherapies and vaccines. It also supports projects addressing unmet medical needs for treating childhood and … Continue reading 23 companies to benefit from share of £12 million from Innovate UK Cancer Therapeutics programme